The Madrid-based group expects to increase its turnover by at least 40-50% more than in 2022.
He Neolife Health Group, The clinical group, a pioneer in Europe in the treatment and optimization of the aging process and the first center in Spain dedicated to its study, expects to achieve a turnover of 1,800,000 euros during the year 2023, which would represent an increase of 50% compared to 2022.
In the previous year, this group has billed 1,200,000 euros thanks to several factors, including: on the one hand, business stability after the pandemic; on the other, the implementation of new services in its centers.
Neolife is the pioneering clinical group in Europe in the treatment and optimization of the aging process and the first center in Spain dedicated to its study, whose objective is to improve the quality of life by preventing diseases.
Neolife has been caring for the health of its patients for almost 10 years in its clinics in Madrid and Marbella. Its team has the highest level of training in hormonal optimization and the experience of thousands of treatments and satisfied patients.
Esther Anzola, CEO & Founder of Neolife, maintains that: “We have begun to change the paradigm of medicine: From 'going to the doctor' when we are sick, we have moved to 'investing in our health,' continuously improving our quality of life and preventing illness. The Neolife method,“ continues Esther Anzola, ”aims to prevent disease, not diagnose it. We optimize the health of each individual and obtain short-, medium-, and long-term benefits, in order to prolong an optimal state of well-being and health for as many years as possible.“.
During 2022, Neolife began its journey in franchising, offering its franchisees a proven business model, with comprehensive training processes, systematic support, management tools fully adapted to the activity, and the security provided by the most extensive experience in developing this activity in Spain—all key factors for the ultimate success of the business.


